BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33450490)

  • 1. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
    Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
    Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation.
    Xie M; Yu T; Jing X; Ma L; Fan Y; Yang F; Ma P; Jiang H; Wu X; Shu Y; Xu T
    Mol Cancer; 2020 Jun; 19(1):112. PubMed ID: 32600329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone, a novel tumor angiogenesis inhibitor, destabilizes tumor necrosis factor-α mRNA via decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR.
    Zhu Z; Zhao Y; Li J; Tao L; Shi P; Wei Z; Sheng X; Shen D; Liu Z; Zhou L; Tian C; Fan F; Shen C; Zhu P; Wang A; Chen W; Zhao Q; Lu Y
    Mol Carcinog; 2016 Oct; 55(10):1399-410. PubMed ID: 26310813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
    Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
    Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in vitro and in vivo.
    Zibara K; Awada Z; Dib L; El-Saghir J; Al-Ghadban S; Ibrik A; El-Zein N; El-Sabban M
    Sci Rep; 2015 Jul; 5():12598. PubMed ID: 26218768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbitacin B inhibits breast cancer metastasis and angiogenesis through VEGF-mediated suppression of FAK/MMP-9 signaling axis.
    Sinha S; Khan S; Shukla S; Lakra AD; Kumar S; Das G; Maurya R; Meeran SM
    Int J Biochem Cell Biol; 2016 Aug; 77(Pt A):41-56. PubMed ID: 27210504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic Trioxide Suppressed Migration and Angiogenesis by Targeting FOXO3a in Gastric Cancer Cells.
    Zhang L; Liu L; Zhan S; Chen L; Wang Y; Zhang Y; Du J; Wu Y; Gu L
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis.
    Gubin MM; Calaluce R; Davis JW; Magee JD; Strouse CS; Shaw DP; Ma L; Brown A; Hoffman T; Rold TL; Atasoy U
    Cell Cycle; 2010 Aug; 9(16):3337-46. PubMed ID: 20724828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
    Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
    Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metalloproteinase-9 expression and proangiogenic activity in breast cancer cells.
    Lee CC; Liu KJ; Wu YC; Lin SJ; Chang CC; Huang TS
    Inflammation; 2011 Jun; 34(3):209-21. PubMed ID: 20617373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
    Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
    J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
    Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
    PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway.
    Peng Y; Wang Y; Tang N; Sun D; Lan Y; Yu Z; Zhao X; Feng L; Zhang B; Jin L; Yu F; Ma X; Lv C
    J Exp Clin Cancer Res; 2018 Oct; 37(1):248. PubMed ID: 30314513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
    Zhang Z; Huang A; Zhang A; Zhou C
    Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
    J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis.
    Bi YL; Mi PY; Zhao SJ; Pan HM; Li HJ; Liu F; Shao LR; Zhang HF; Zhang P; Jiang SL
    Int J Mol Med; 2017 May; 39(5):1255-1261. PubMed ID: 28358414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.